Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. [electronic resource]
- Blood Aug 2008
- 1539-42 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1528-0020
10.1182/blood-2008-02-138867 doi
Adolescent Adult Aged Child Child, Preschool Female Graft vs Host Disease--diagnosis Hematopoietic Stem Cell Transplantation--adverse effects Humans Incidence Infant Infant, Newborn Male Middle Aged Myeloablative Agonists--therapeutic use Predictive Value of Tests Prognosis Receptors, Tumor Necrosis Factor, Type I--blood Survival Rate Time Factors Transplantation Conditioning--adverse effects Transplantation, Homologous Tumor Necrosis Factor-alpha--analysis